{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:29:58Z","timestamp":1786984198422,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870670"],"award-info":[{"award-number":["81870670"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000907"],"award-info":[{"award-number":["82000907"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171078"],"award-info":[{"award-number":["82171078"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18411965100"],"award-info":[{"award-number":["18411965100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004241","name":"China Primary Health Care Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ajo.2023.03.010","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T12:39:49Z","timestamp":1679488789000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Longitudinal Analysis of Ocular Manifestation and Interleukin During Intravitreal Treatment of Vitreoretinal Lymphoma With Methotrexate"],"prefix":"10.1016","volume":"251","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3420-2247","authenticated-orcid":false,"given":"Junxiang","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhujian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gezhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3733-8980","authenticated-orcid":false,"given":"Qing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ajo.2023.03.010_bib0001","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","article-title":"Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium","volume":"16","author":"Chan","year":"2011","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.ajo.2023.03.010_bib0002","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ajo.2023.03.010_bib0003","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13045-022-01356-7","article-title":"Evidence-based expert consensus on the management of primary central nervous system lymphoma in China","volume":"15","author":"Chen","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"17","key":"10.1016\/j.ajo.2023.03.010_bib0004","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood.2020008235","article-title":"Primary vitreoretinal lymphoma: a diagnostic and management challenge","volume":"138","author":"Soussain","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ajo.2023.03.010_bib0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/bjh.17451","article-title":"Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma - 20 years of experience","volume":"194","author":"Habot-Wilner","year":"2021","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.ajo.2023.03.010_bib0006","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/bjh.14025","article-title":"How we diagnose and treat vitreoretinal lymphoma","volume":"173","author":"Fend","year":"2016","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.010_bib0007","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00277-015-2582-x","article-title":"Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection","volume":"95","author":"Ma","year":"2016","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.ajo.2023.03.010_bib0008","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/bjh.14848","article-title":"Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma","volume":"179","author":"Kaburaki","year":"2017","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.010_bib0009","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/09273948.2019.1616769","article-title":"Retinal and choroidal changes of vitreoretinal lymphoma from active to remission phase after intravitreal rituximab","volume":"28","author":"Cicinelli","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ajo.2023.03.010_bib0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12886-019-1300-1","article-title":"Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2023.03.010_bib0011","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00417-011-1718-5","article-title":"Repeated IL-10 measurement in aqueous humor and OCT imaging are valuable tools to monitor intraocular lymphoma treated with intravitreal injections of methotrexate","volume":"250","author":"Saleh","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2023.03.010_bib0012","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40942-018-0120-4","article-title":"The diagnosis and treatment of primary vitreoretinal lymphoma: a review","volume":"4","author":"Pulido","year":"2018","journal-title":"Int J Retina Vitreous"},{"issue":"6","key":"10.1016\/j.ajo.2023.03.010_bib0013","doi-asserted-by":"crossref","first-page":"e65627","DOI":"10.1371\/journal.pone.0065627","article-title":"Effect of intravitreal methotrexate and rituximab on interleukin-10 levels in aqueous humor of treated eyes with vitreoretinal lymphoma","volume":"8","author":"Raja","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ajo.2023.03.010_bib0014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bjo.2007.127928","article-title":"Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience","volume":"92","author":"Frenkel","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2023.03.010_bib0015","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.autrev.2017.08.002","article-title":"Targeting interleukin-6 in autoimmune uveitis","volume":"16","author":"Mesquida","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.ajo.2023.03.010_bib0016","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1167\/iovs.16-19758","article-title":"The cytokine interleukin-6 and the chemokines CCL20 and CXCL13 are novel biomarkers of specific endogenous uveitic entities","volume":"57","author":"Abu","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2023.03.010_bib0017","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40942-021-00346-0","article-title":"Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma","volume":"7","author":"Anthony","year":"2021","journal-title":"Int J Retina Vitreous"},{"issue":"1","key":"10.1016\/j.ajo.2023.03.010_bib0018","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/bjophthalmol-2013-304043","article-title":"Use of intravitreal rituximab for treatment of vitreoretinal lymphoma","volume":"98","author":"Larkin","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.03.010_bib0019","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12886-020-01464-3","article-title":"Reduced frequency of intravitreal methotrexate injection lowers the risk of keratopathy in vitreoretinal lymphoma patients","volume":"20","author":"Zhou","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2023.03.010_bib0020","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1097\/IAE.0000000000003241","article-title":"Clinical features, diagnostic significance, and prognosis of vitreoretinal lymphoma in young patients","volume":"41","author":"Liu","year":"2021","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ajo.2023.03.010_bib0021","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41433-021-01657-0","article-title":"A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma","volume":"36","author":"Zhou","year":"2022","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.010_bib0022","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/IAE.0000000000001922","article-title":"Use of a threshold of interleukin-10 and IL-10\/IL-6 ratio in ocular samples for the screening of vitreoretinal lymphoma","volume":"38","author":"Pochat-Cotilloux","year":"2018","journal-title":"Retina"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423001186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423001186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:54:03Z","timestamp":1757598843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423001186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":22,"alternative-id":["S0002939423001186"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.03.010","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Analysis of Ocular Manifestation and Interleukin During Intravitreal Treatment of Vitreoretinal Lymphoma With Methotrexate","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}